Newsletter Archive

91. 04.17.24 -- What's In The Vial?! A Meditation On mRNA Control Strategy 4/17/2024
    04/17/24 Advancing RNA Newsletter
92. 04.10.24 -- The 3 C's Of mRNA-LNP Raw Material Sourcing 4/10/2024
    04/10/24 Advancing RNA Newsletter
93. 04.08.24 -- The Business of Biotech: Leaders in ADC Technologies 4/8/2024

    04/08/24 Advancing RNA Newsletter

94. 04.03.24 -- Comparability Considerations For mRNA Product Development 4/3/2024
    04/03/24 Advancing RNA Newsletter
95. 04.02.24 -- CRISPR Therapies And The Regulatory Landscape 4/2/2024

    04/02/24 Advancing RNA Newsletter

96. 03.27.24 -- FDA's Gene Editing Guidance: New & Remaining Questions 3/27/2024
    03/27/24 Advancing RNA Newsletter
97. 03.25.24 -- End-To-End Services And Solutions For Your RNA Manufacturing 3/25/2024
    03/25/24 Advancing RNA Newsletter
98. 03.20.24 -- Shakespeare's Guide To RNA Therapeutics GMP Principles 3/20/2024
    03/20/24 Advancing RNA Newsletter
99. 03.14.24 -- Regulatory & GMP Manufacturing Insights Into mRNA-LNP Drug Products 3/14/2024

    03/14/24 Advancing RNA Newsletter

100. 03.13.24 -- mRNA Meets Violin Making: What Can We Learn From Violin Makers? 3/13/2024
     03/13/24 Advancing RNA Newsletter